These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. American Chemical Society--229th National Meeting. Kinase modulators. Mackonochie M; Chan D IDrugs; 2005 Apr; 8(4):283-4. PubMed ID: 15800796 [No Abstract] [Full Text] [Related]
3. Drug discovery process for kinase inhibitors. Weinmann H; Metternich R Chembiochem; 2005 Mar; 6(3):455-9. PubMed ID: 15742380 [No Abstract] [Full Text] [Related]
4. Medicinal Chemistry - XXth International Symposium. Lead finding strategies and kinase selectivity. Rotella DP IDrugs; 2008 Nov; 11(11):774-8. PubMed ID: 18988116 [No Abstract] [Full Text] [Related]
5. 19th International Symposium on Medicinal Chemistry. Baker M ACS Chem Biol; 2006 Oct; 1(9):549-53. PubMed ID: 17168546 [TBL] [Abstract][Full Text] [Related]
7. Medicinal chemistry--29th National Symposium. SERMs and SARMs. Lackey K IDrugs; 2004 Aug; 7(8):729-31. PubMed ID: 15334304 [No Abstract] [Full Text] [Related]
8. Editorial:Shaping Current and Future Kinase Drug Discovery. Bhalla N Curr Top Med Chem; 2017; 17(22):2469. PubMed ID: 28799507 [No Abstract] [Full Text] [Related]
9. Exploiting polypharmacology for improving therapeutic outcome of kinase inhibitors (KIs): An update of recent medicinal chemistry efforts. Ma X; Lv X; Zhang J Eur J Med Chem; 2018 Jan; 143():449-463. PubMed ID: 29202407 [TBL] [Abstract][Full Text] [Related]
10. Small-molecule kinase-inhibitor target assessment. Kung C; Shokat KM Chembiochem; 2005 Mar; 6(3):523-6. PubMed ID: 15696508 [TBL] [Abstract][Full Text] [Related]
11. Early career research in medicinal chemistry. Baell JB Future Med Chem; 2021 Jan; 13(2):91-93. PubMed ID: 33487046 [No Abstract] [Full Text] [Related]
12. Recent developments in the discovery of protein kinase inhibitors from the urea class. Dumas J; Smith RA; Lowinger TB Curr Opin Drug Discov Devel; 2004 Sep; 7(5):600-16. PubMed ID: 15503863 [TBL] [Abstract][Full Text] [Related]
13. Assessment of chemical coverage of kinome space and its implications for kinase drug discovery. Bamborough P; Drewry D; Harper G; Smith GK; Schneider K J Med Chem; 2008 Dec; 51(24):7898-914. PubMed ID: 19035792 [TBL] [Abstract][Full Text] [Related]
14. Rational design of inhibitors that bind to inactive kinase conformations. Liu Y; Gray NS Nat Chem Biol; 2006 Jul; 2(7):358-64. PubMed ID: 16783341 [TBL] [Abstract][Full Text] [Related]
17. Design strategies for protein kinase inhibitors. Parang K; Sun G Curr Opin Drug Discov Devel; 2004 Sep; 7(5):617-29. PubMed ID: 15503864 [TBL] [Abstract][Full Text] [Related]
18. Knowledge-based design of 7-azaindoles as selective B-Raf inhibitors. Tang J; Hamajima T; Nakano M; Sato H; Dickerson SH; Lackey KE Bioorg Med Chem Lett; 2008 Aug; 18(16):4610-4. PubMed ID: 18662874 [TBL] [Abstract][Full Text] [Related]
19. Advancing the kinase field: new targets and second generation inhibitors. Laufer S; Bajorath J J Med Chem; 2015 Jan; 58(1):1. PubMed ID: 25490234 [No Abstract] [Full Text] [Related]
20. Targeting the DFG-in kinase conformation: a new trend emerging from a patent analysis. Angiolini M Future Med Chem; 2011 Mar; 3(3):309-37. PubMed ID: 21446845 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]